MedinCell S.A.
MedinCell S.A. (PAR: MEDCL) is trading at €23.02, about ₹2,518 at today's EUR/INR rate, as of 25 Sep 2026, 11:35 AM ET, down 2.04% today. Indian residents can buy MedinCell from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€22.78
Today's high
€23.44
52 week low
€19.69
52 week high
€39.68
MEDCL opened at €23.44, closed previously at €23.50, and has traded between €19.69 and €39.68 over the past 52 weeks.
About
MedinCell S.A. specializes in pioneering diverse therapeutic treatments. At the core of its development lies BEPO, a cutting-edge technology that enables the creation of long-acting injectable pharmaceutical products. This system leverages a unique combination of proprietary copolymers and a biocompatible solvent to effectively dissolve or suspend active drug compounds. The company's advanced pipeline includes several key products: mdc-IRM, a subcutaneous injection currently in Phase III clinical trials for the treatment of schizophrenia; mdc-CWM, an intra-articular injection designed to address pain and inflammation; and mdc-TJK, another subcutaneous injection targeting schizophrenia, presently in preclinical development. MedinCell is also actively engaged in formulation research for additional product candidates. These encompass subcutaneous injections such as mdc-WWM for contraception, mdc-ANG for central nervous system-related conditions, mdc-ELK for depression, and mdc-GRT for organ transplant applications. Furthermore, the firm is investigating perineural injections like mdc-CMV for anesthesia and pain management, and mdc-NVA, also intended for pain relief. MedinCell S.A. maintains its headquarters in Jacou, France.
Key statistics
Avg. volume
86.07K
Market cap
€826.68M
P/E Ratio
-25.30
Price-to-sales ratio
42.35
Enterprise value
€821.30M
Free cash flow yield
-3.13%
Debt-to-equity ratio
18.74
Return on equity
226.98%
ROIC
-24.37%
Beta
0.97
Dividend yield
0.00%
Last dividend
€0.00
Financial overview
Revenue
€19.52M
Earnings per share
-€0.87
Free cash flow
-€26.60M
Net profit margin
-160.30%
Gross margin
51.90%
EBITDA
-€23.67M
Revenue growth
-23.57%
Similar securities
This is not an investment recommendation
How to buy MedinCell from India
Indian residents can buy MedinCell shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for MedinCell and place an order
Find MedinCell by name or by its ticker, MEDCL, and choose an order type. MedinCell trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your MedinCell position in EUR and INR. MedinCell pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in MedinCell from India
Trading and taxes when buying MedinCell from India
Trading and limits
- Trading hours
- 9:00 am – 5:30 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneMedinCell does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy MedinCell stock?
Yes. MedinCell (MEDCL) has been listed on Euronext Paris since 2018, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one MedinCell share cost in rupees?
One MedinCell share is €23.02 — about ₹2,518 at an EUR/INR rate of 109.37 on 25 Sep 2026. Both the MedinCell price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying MedinCell from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on MedinCell shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the MedinCell price. Paasa issues a capital-gains statement for your return.
Does MedinCell pay a dividend?
No. MedinCell does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade MedinCell from India?
Euronext Paris trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when France is on standard time. Orders can only execute during that window.
Do I have to declare MedinCell shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your MedinCell holding, its cost and its closing value.
How do I sell MedinCell and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on MedinCell?
Yes. MedinCell is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.